Follows people with Parkinson's disease after focused ultrasound brain surgery
Follows adults with advanced Parkinson's disease after Exablate pallidotomy, a focused ultrasound treatment.
Plain-language title generated from the registry record
Registry title: A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
Key facts
- Where
- Akashi, JapanSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 30 and 99 years old?
Source: NCT05539196, who can take part
Where in Japan
- Ohnishi Neurological CenterAkashi, JapanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- InSightec
- Trial code
- NCT05539196
- Record updated
- 20 March 2026
- Original description
This registry is a prospective, multicenter, international, single arm, observational post-approval registry with follow-up at 3, 6, and 12 months, and annually for 5 years. The proposed registry will enroll 60 subjects and will be conducted at approximately 10 centers worldwide.Read full original descriptionShow less
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
This registry is a prospective, multicenter, international, single arm, observational post-approval registry with follow-up at 3, 6, and 12 months, and annually for 5 years. The proposed registry will enroll 60 subjects and will be conducted at approximately 10 centers worldwide.
Inclusion: Men and women, age 30 years and older; Subject undergoing a planned an Exablate procedure for their Parkinson's Disease with Motor Complications per local institution standard of care; Subject is willing to cooperate with the Registry requirements including compliance with the regimen and completion of all Registry visits; Subject has signed and received a copy of the approved informed consent form.
Exclusion: Subject does not agree to participate or is unlikely to participate for the entirety of the Registry.